Discovery of a novel natural killer cell line with distinct immunostimulatory and proliferative potential as an alternative platform for cancer immunotherapy

BACKGROUND: Human natural killer (NK) cell lines serve as an attractive source for adoptive immunotherapy, but NK-92 remains the only cell line being assessed in the clinic. Here, we established a novel NK cell line, NK101, from a patient with extra-nodal natural killer/T-cell lymphoma and examined...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Hyun Gul, Kang, Moon Cheol, Kim, Tae Yoon, Hwang, Injung, Jin, Hyun Tak, Sung, Young Chul, Eom, Ki-Seong, Kim, Sae Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534912/
https://www.ncbi.nlm.nih.gov/pubmed/31126350
http://dx.doi.org/10.1186/s40425-019-0612-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534912/
https://www.ncbi.nlm.nih.gov/pubmed/31126350
http://dx.doi.org/10.1186/s40425-019-0612-2

Ejemplares similares